HCA Healthcare Inc reports results for the quarter ended June 30 - Earnings Summary
HCA Healthcare Inc reports results for the quarter ended June 30 - Earnings Summary
HCA Healthcare Inc HCA.N reported quarterly adjusted earnings of $7.62 per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $6.83. The mean expectation of twenty two analysts for the quarter was for earnings of $7.47 per share. Wall Street expected results to range from $6.80 to $8.58 per share.
Revenue rose 8.7% to $20.23 billion from a year ago; analysts expected $19.43 billion.
HCA Healthcare Inc's reported EPS for the quarter was $7.62.
The company reported quarterly net income of $1.7 billion.
HCA Healthcare Inc shares had fallen by 3.4% this quarter and lost 19.4% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 0.6% in the last three months.
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy," 11 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is also "buy"
Wall Street's median 12-month price target for HCA Healthcare Inc is $462.50, about 18.6% above its last closing price of $376.50
This summary was machine generated from LSEG data July 24 at 01:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 7.47 | 7.62 | Beat |
Mar. 31 2026 | 7.14 | 7.15 | Beat |
Dec. 31 2025 | 7.46 | 8.14 | Beat |
Sep. 30 2025 | 5.72 | 6.96 | Beat |
Recent news on HCA Healthcare
See all newsLive Markets: Split US congress after 2026 midterms could boost healthcare stocks, Mizuho says
Focus: Americans navigate 'wild West' of health insurance options after dropping Obamacare plans
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
U.S. RESEARCH ROUNDUP-Amgen, Analog Devices, Moderna
Brief: HCA Healthcare Increases Commercial Paper Program Size To $8.0 Billion From $4.0 Billion - Filing